Your browser doesn't support javascript.
loading
High prevalence of antinuclear antibodies and lupus anticoagulant in patients hospitalized for SARS-CoV2 pneumonia.
Gazzaruso, Carmine; Carlo Stella, Nicoletta; Mariani, Giuseppe; Nai, Carlo; Coppola, Adriana; Naldani, Daniela; Gallotti, Pietro.
  • Gazzaruso C; Emergency Unit and Endocrinology Unit, Istituto Clinico "Beato Matteo" (Hospital Group San Donato), Corso Pavia, 84, 27029, Vigevano, Italy. c.gazzaruso@gmail.com.
  • Carlo Stella N; Centre for Applied Clinical Research (Ce.R.C.A.), Istituto Clinico "Beato Matteo" (Hospital Group San Donato), Vigevano, Italy. c.gazzaruso@gmail.com.
  • Mariani G; Internal Medicine, Oncology and Rheumatology Unit, Istituto Clinico "Beato Matteo" (Hospital Group San Donato), Vigevano, Italy.
  • Nai C; Internal Medicine, Oncology and Rheumatology Unit, Istituto Clinico "Beato Matteo" (Hospital Group San Donato), Vigevano, Italy.
  • Coppola A; Internal Medicine, Oncology and Rheumatology Unit, Istituto Clinico "Beato Matteo" (Hospital Group San Donato), Vigevano, Italy.
  • Naldani D; Centre for Applied Clinical Research (Ce.R.C.A.), Istituto Clinico "Beato Matteo" (Hospital Group San Donato), Vigevano, Italy.
  • Gallotti P; Clinical Pathology, Istituto Clinico "Beato Matteo" (Hospital Group San Donato), Vigevano, Italy.
Clin Rheumatol ; 39(7): 2095-2097, 2020 07.
Article en En | MEDLINE | ID: mdl-32462425

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neumonía / COVID-19 Tipo de estudio: Prevalence_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2020 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neumonía / COVID-19 Tipo de estudio: Prevalence_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2020 Tipo del documento: Article